What changed in this filing

/stocks — the workspaceLOADING

Item 1. Financial Statements

2023-02-14 compared with 2022-11-04 · 124 added, 109 removed, 395 unchanged (37% of the section changed)

2 unchanged sentences

CONDENSED CONSOLIDATED BALANCE SHEET S

September 30,

(In thousands, except share

31 unchanged sentences

Accumulated other comprehensive loss

Retained earnings

Retained earnings (deficit)

Total stockholders’ equity

3 unchanged sentences

CONDENSED CONSOLIDATED STATEMENTS OF OPERATION S

Three Months Ended September 30,

Six Months Ended September 30,

Three Months Ended December 31,

Nine Months Ended December 31,

(In thousands, except per share amounts)

15 unchanged sentences

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS

Three Months Ended September 30,

Six Months Ended September 30,

Three Months Ended December 31,

Nine Months Ended December 31,

(In thousands)

8 unchanged sentences

Income (Loss)

Three months ended September 30, 2022

Earnings (Deficit)

Three months ended December 31, 2022

(In thousands, except share amounts)

Balance, June 30, 2022

Balance, September 30, 2022

Issuance of common stock under employee stock option plans

Stock-based compensation expense

Net unrealized gain on available-for-sale investments

Balance, December 31, 2022

Three months ended December 31, 2021

Balance, September 30, 2021

Three months ended September 30, 2021

Balance, June 30, 2021

Issuance of common stock under employee stock option plans

1 unchanged sentence

Net unrealized loss on available-for-sale investments

Balance, September 30, 2021

Balance, December 31, 2021

Comprehensive

1 unchanged sentence

Income (Loss)

Six months ended September 30, 2022

Earnings (Deficit)

Nine months ended December 31, 2022

(In thousands, except share amounts)

2 unchanged sentences

Stock-based compensation expense

Net unrealized loss on available-for-sale investments

Balance, September 30, 2022

Six months ended September 30, 2021

Net unrealized gain on available-for-sale investments

Balance, December 31, 2022

Nine months ended December 31, 2021

Balance, March 31, 2021

2 unchanged sentences

Net unrealized loss on available-for-sale investments

Balance, September 30, 2021

Balance, December 31, 2021

The accompanying notes are an integral part of these condensed consolidated financial statements.

1 unchanged sentence

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOW S

Six Months Ended September 30,

Nine Months Ended December 31,

(In thousands)

18 unchanged sentences

Purchases of property and equipment

Net cash provided by investing activities

Net cash provided by (used in) investing activities

Cash flows from financing activities:

20 unchanged sentences

However, these financial statements should be read in conjunction with the audited consolidated financial statements and related notes thereto included in the Company’s Annual Report on Form 10-K for the fiscal year ended March 31, 2022.

The consolidated results of operations for the six months ended September 30, 2022 are not necessarily indicative of the results to be expected for the entire fiscal year.

The consolidated results of operations for the nine months ended December 31, 2022 are not necessarily indicative of the results to be expected for the entire fiscal year.

Reclassifications

5 unchanged sentences

Governments in affected regions have implemented, and may continue to implement, safety precautions including quarantines, travel restrictions, business closures, cancellations of public gatherings and other measures as they deem necessary.

Many organizations and individuals, including the Company and its employees, are taking additional steps to avoid or reduce infection, including limiting travel and working from home.

These measures are disrupting normal business operations and have had significant negative impacts on businesses and financial markets worldwide.

Many organizations and individuals, including the Company and its employees, took additional steps to avoid or reduce infection, including limiting travel and working from home.

These measures have disrupted normal business operations and have had significant negative impacts on businesses and financial markets worldwide.

The Company continues to monitor its operations and government recommendations and has made modifications to its normal operations because of the COVID-19 global pandemic.

The Company has instituted many preventative measures and is regularly evaluating those measures and others as it continues to better understand its current and future operating environment.

The majority of our employees around the world worked from home for extended timeframes due to the pandemic.

The Company maintained a substantial portion of its manufacturing operational capacity at its primary manufacturing support facility located in Hsin Chu, Taiwan where the Company’s suppliers are located and where all of the Company’s products are manufactured.

Since the outbreak of COVID-19, aside from supply chain shortages from the lengthening of lead times for wafers and assembly services and the impact of ongoing and expected price increases, including a 20 % increase in the cost of wafers received in early calendar 2022 and a 6 % increase expected in early calendar 2023, the Company has experienced minimal impact, and continues to experience minimal impact, on its manufacturing operations in Taiwan.

testing of the Company’s products is conducted in house in both the US and Taiwan.

Shipping and receiving operations were maintained by a skeleton crew with minimal impact.

Since the outbreak of COVID-19, aside from supply chain shortages from the lengthening of lead times for wafers and assembly services and the impact of ongoing and expected price increases, including a 20 % increase in the cost of wafers received in early calendar 2022 and a 6 % increase in early calendar 2023, the Company has experienced minimal impact, and continues to experience minimal impact, on its manufacturing operations in Taiwan.

Final testing of the Company’s products is conducted in house in both the US and Taiwan.

The Company’s revenues were impacted by changes in customer buying patterns and communication limitations related to COVID-19 restrictions that required a significant number of its customer contacts to work from home.

The Company’s results for the fiscal years ended March 31, 2022 and 2021 demonstrated the challenges that the Company has faced during the COVID-19 global pandemic, which has restricted the activities of the Company’s sales force and distributors, reduced customer demand and caused the postponement of investment in certain customer sectors.

caused the postponement of investment in certain customer sectors.

These challenges have also impacted the Company as it entered new markets and engaged with target customers to sell its new APU product.

2 unchanged sentences

In addition to the continuing COVID-19 global pandemic, the recent military conflict in Ukraine, the rapid rise in energy prices, worldwide inflationary pressures, rising interest rates and decline in the global economic environment may have an adverse impact on the Company’s business and financial condition.

The disruption to the marketplace resulting from the COVID-19 global pandemic that the Company continues to experience is unlike anything the Company has ever had to deal with.

While the Company continues to monitor the business metrics that it has historically used to predict its financial performance, the Company is uncertain as to whether these metrics will operate consistently with its historical experience.

The Company believes that during the next 12 months the COVID-19 global pandemic could impact general economic activity and demand in its end markets.

Although the Company cannot estimate the length or gravity of the impact of the COVID-19 outbreak, if the pandemic continues, it will have an adverse effect on the Company’s results of operations, financial position, including potential impairments, and liquidity in fiscal year 2023.

This expectation includes results from new information that may emerge concerning COVID-19, the effectiveness of vaccines and any actions taken to contain or treat COVID-19, as well as the economic impact on local, regional, national and international customers and markets.

The Company has made estimates of the impact of COVID-19 within its condensed consolidated financial statements and there may be changes to those estimates in future periods that could be material.

Accounting pronouncements not yet effective for fiscal 2023

In June 2016, the FASB issued ASU No.

In June 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No.

2016-13, “Financial Instruments—Credit Losses (Topic 326):

13 unchanged sentences

The majority of the Company’s customer contracts, which may be in the form of purchase orders, contracts or purchase agreements, contain performance obligations for delivery of agreed upon products.

Delivery of all performance obligations contained within a contract with a customer typically occurs at the same time (or within the

same accounting period).

Delivery of all performance obligations contained within a contract with a customer typically occurs at the same time (or within the same accounting period).

Transfer of control typically occurs at the point at which delivery has occurred, title and the risks and rewards of ownership have passed to the customer, and the Company has a right to payment.

1 unchanged sentence

For consignment sales, which are infrequent, revenue is recognized at the time that the product is pulled from consignment warehouses.

Because all of the Company’s performance obligations relate to contracts with a duration of less than one year, the Company has elected to apply the optional exemption practical expedient provided in ASC 606 and, therefore, is not required to disclose the aggregate amount of the transaction price allocated to performance obligations that are unsatisfied or partially unsatisfied at the end of the reporting period.

Because all of the Company’s performance obligations relate to contracts with a duration of less than one year, the Company has elected to apply the optional exemption practical expedient and, therefore, is not required to disclose the aggregate amount of the transaction price allocated to performance obligations that are unsatisfied or partially unsatisfied at the end of the reporting period.

The Company adjusts the transaction price for variable consideration.

Variable consideration is not typically significant and primarily results from stock rotation rights and quick pay discounts provided to certain distributors.

As a practical expedient, the Company is recognizing the incremental costs of obtaining a contract, specifically commission expenses that have a period of benefit of less than twelve months, as an expense when incurred.

As a practical expedient, the Company is recognizing the incremental costs of obtaining a contract,

specifically commission expenses that have a period of benefit of less than twelve months, as an expense when incurred.

Additionally, the Company has adopted an accounting policy to recognize shipping costs that occur after control transfers to the customer as a fulfillment activity.

7 unchanged sentences

The Company estimates its warranty costs based on historical warranty claim experience and includes such costs in cost of revenues.

Warranty costs and the accrued warranty liability were not material as of September 30, 2022.

The majority of the Company’s revenue is derived from sales of SRAM products which represent approximately 96 % and 98 % of total revenues in the six months ended September 30, 2022 and 2021, respectively.

Warranty costs and the accrued warranty liability were not material as of December 31, 2022 and March 31, 2022.

The majority of the Company’s revenue is derived from sales of SRAM products, which represent approximately 98 % and 96 % of total revenues in the three months ended December 31, 2022 and 2021, respectively and 97 % and 98 % of total revenues in the nine months ended December 31, 2022 and 2021, respectively.

Nokia, the Company’s largest customer, purchases products directly from the Company and through contract manufacturers and distributors.

Based on information provided to the Company by its contract manufacturers and distributors, purchases by Nokia represented approximately 14 % and 24 % of the Company’s net revenues in the three months ended September 30, 2022 and 2021, respectively, and 14 % and 34 % of the Company’s net revenues in the six months ended September 30, 2022 and 2021, respectively.

Based on information provided to the Company by its contract manufacturers and distributors, purchases by Nokia represented approximately 20 % and 24 % of the Company’s net revenues in the three months ended December 31, 2022 and 2021, respectively, and 16 % and 31 % of the Company’s net revenues in the nine months ended December 31, 2022 and 2021, respectively.

See “Note 12 — Segment and Geographic Information” for revenue by shipment destination.

The following table presents the Company’s revenue disaggregated by customer type.

Three Months Ended September 30,

Six Months Ended September 30,

Three Months Ended December 31,

Nine Months Ended December 31,

(In thousands)

4 unchanged sentences

The following table sets forth the computation of basic and diluted net loss per share:

Three Months Ended September 30,

Six Months Ended September 30,

Three Months Ended December 31,

Nine Months Ended December 31,

(In thousands, except per share amounts)

8 unchanged sentences

The following shares of common stock underlying outstanding stock options, determined on a weighted average basis, were excluded from the computation of diluted net loss per share as they had an anti-dilutive effect:

Three Months Ended September 30,

Six Months Ended September 30,

Three Months Ended December 31,

Nine Months Ended December 31,

(In thousands)

2 unchanged sentences

NOTE 4—BALANCE SHEET DETAIL

September 30, 2022

December 31, 2022

March 31, 2022

3 unchanged sentences

Inventory at distributors

September 30, 2022

December 31, 2022

March 31, 2022

3 unchanged sentences

Allowances for doubtful accounts and other

September 30, 2022

December 31, 2022

March 31, 2022

4 unchanged sentences

Other prepaid expenses and other current assets

September 30, 2022

December 31, 2022

March 31, 2022

6 unchanged sentences

Accumulated depreciation

Depreciation expense was $ 196,000 and $ 197,000 for the three months ended September 30, 2022 and 2021, respectively, and $ 393,000 and $ 384,000 for the six months ended September 30, 2022 and 2021.

The following tables summarize the components of intangible assets and related accumulated amortization balances at September 30, 2022 and March 31, 2022 (in thousands):

As of September 30, 2022

Depreciation expense was $ 195,000 and $ 193,000 for the three months ended December 31, 2022 and 2021, respectively, and $ 588,000 and $ 577,000 for the nine months ended December 31, 2022 and 2021, respectively.

The following tables summarize the components of intangible assets and related accumulated amortization balances at December 31, 2022 and March 31, 2022 (in thousands):

As of December 31, 2022

Intangible assets:

3 unchanged sentences

Product designs

Amortization of intangible assets included in cost of revenues was $ 58,000 and $ 58,000 for the three months ended September 30, 2022 and 2021, respectively, and $ 117,000 and $ 117,000 for the six months ended September 30, 2022 and 2021.

Amortization of intangible assets included in cost of revenues was $ 58,000 for each of the three months ended December 31, 2022 and 2021, and $ 175,000 for each of the nine months ended December 31, 2022 and 2021.

The Company reviews identifiable amortizable intangible assets for impairment whenever events or changes in circumstances indicate that the carrying value of the assets may not be recoverable.

1 unchanged sentence

Measurement of any impairment loss is based on the excess of the carrying value of the asset over its fair value.

Based on the uncertainty of forecasts, events such as the failure to generate revenue from future product launches could result in impairment in the future.

The Company identified a potential impairment indicator for the finite lived intangible assets and performed a recoverability test by comparing the sum of the estimated undiscounted future cash flows of the asset group to the carrying amount as of March 31, 2022.

The result of the recoverability test indicated that the sum of the expected future cash flows was greater than the carrying amount of the finite lived intangible assets.

The result of the recoverability tests indicated that the sum of the expected future cash flows was greater than the carrying amount of the finite lived intangible assets.

Based on the uncertainty of forecasts inherent with a new product, events such as the failure to generate forecasted revenue from the APU product could result in a non-cash impairment charge in future periods.

As of September 30, 2022, the estimated future amortization expense of intangible assets in the table above is as follows (in thousands):

As of December 31, 2022, the estimated future amortization expense of intangible assets in the table above is as follows (in thousands):

Fiscal year ending March 31,

2023 (remaining six months)

September 30, 2022

2023 (remaining three months)

December 31, 2022

March 31, 2022

5 unchanged sentences

Miscellaneous accrued expenses

On November 30, 2022, the Company announced cost reduction initiatives which included an approximate 15 % reduction in the Company’s global workforce.

The Company incurred $ 0.3 million in severance related charges during the three and nine months ended December 31, 2022 including $ 0.1 million recorded as cost of revenues and $ 0.2 million recorded as selling, general and administrative expense in the condensed consolidated statements of operations.

The Company expects to incur an additional $ 0.3 million in severance related charges during the three months ending March 31, 2023.

There were no severance charges accrued as of December 31, 2022 as the terms of the severance benefits have not been communicated to employees expected to be impacted.

There was no accrued severance as of March 31, 2022 and there were no severance charges incurred during the year ended March 31, 2022.

NOTE 5—GOODWILL

3 unchanged sentences

The Company assesses goodwill for impairment on an annual basis on the last day of February in the fourth quarter of its fiscal year.

The Company had a goodwill balance of $ 8.0 million as of both September 30, 2022 and March 31, 2022.

Goodwill Impairment Test

The Company had a goodwill balance of $ 8.0 million as of both December 31, 2022 and March 31, 2022.

The goodwill resulted from the acquisition of MikaMonu Group Ltd.

in fiscal 2016.

The Company completed its annual impairment test during the fourth quarter of fiscal 2022 and concluded that there was no impairment, as the fair value of its sole reporting unit exceeded its carrying value.

The Company believes that no triggering event has taken place through September 30, 2022.

However, with the macroeconomic uncertainty and decline in the Company’s stock price, there could be a non-cash charge for impairment in a future period should the decline in stock price subsequent to September 30, 2022 be sustained, due to a potential loss of significant customers, or due to a weakened demand for its products.

As additional facts and circumstances evolve, the Company will continue to observe and assess whether an impairment trigger has occurred.

To the extent it becomes more likely than not that the fair value of the Company is less than its carrying amount, the Company will be required to perform a quantitative impairment test, which may result in a non-cash impairment charge in future periods.

During the three months ended December 31, 2022, management identified a sustained decline in the Company’s stock price that resulted in the Company’s market capitalization being below the carrying value of its stockholders’ equity.

The Company concluded the sustained decline in its stock price was a triggering event and proceeded with a quantitative goodwill impairment assessment.

The quantitative impairment assessment was performed as of December 1, 2022, utilizing an equal weighting of the income approach and market comparable approach.

The analysis required the comparison of the Company’s carrying value with its fair value, with an impairment recorded for any excess of carrying value over the fair value.

The income approach utilized a discounted cash flow analysis to determine the fair value of the Company’s single reporting unit.

Key assumptions used in the discounted cash flow analysis included, but are not limited to, a discount rate of approximately 23.5 % to account for risk in achieving the forecast and a terminal growth rate for cash flows of 3.0 %.

The market comparable method was used to determine the fair value of the reporting unit by multiplying forecasted revenue by a market multiple.

The revenue market multiple was calculated by comparing the enterprise value to revenue for comparable companies in the semiconductor industry and then

applying a control premium.

The equal weighting of the income approach and the market comparable method was then reconciled to the market approach.

The market approach was calculated by multiplying the average closing share price of the Company’s common stock for the 30 days prior to the measurement date, by the number of outstanding shares of the Company’s common stock and adding a control premium that reflected the premium a hypothetical buyer might pay.

The control premium was estimated using historical acquisition transactions in the semiconductor industry over the past five years .

The results of the quantitative analysis performed indicated the fair value of the reporting unit exceeded its carrying value.

As a result, the Company concluded there was no goodwill impairment as of December 31, 2022.

A number of significant assumptions and estimates are involved in the income approach and the market comparable method.

The income approach assumes the future cash flows reflect market expectations.

The market comparable method requires an estimate of a revenue market multiple and an appropriate control premium.

These fair value measurements require significant judgements using Level 3 inputs, such as discounted cash flows from operations and revenue forecasts, which are not observable from the market, directly or indirectly.

There is uncertainty in the projected future cash flows used in the Company’s impairment analysis, which requires the use of estimates and assumptions.

If actual performance does not achieve the projections, if there is a further decline in the Company’s stock price, or if the assumptions used in the analysis change in the future, the Company may be required to recognize impairment charges in future periods.

Key assumptions in the market approach include determining the control premium .

The Company believes its procedures for determining fair value are reasonable and consistent with current market conditions as of December 31, 2022.

NOTE 6—INCOME TAXES

The current portion and long-term portion of the Company’s income tax liability related to unrecognized tax benefits was $ 0 at both September 30, 2022 and March 31, 2022.

As of September 30, 2022, $ 3.6 million of unrecognized tax benefits had been recorded as a reduction to net deferred tax assets.

Due to historical losses in the U.S., the Company has a full valuation allowance on its U.S.

federal and state deferred tax assets.

The current portion and long-term portion of the Company’s income tax liability related to unrecognized tax benefits was $ 0 at both December 31, 2022 and March 31, 2022.

As of December 31, 2022, $ 3.7 million of unrecognized tax benefits had been recorded as a reduction to net deferred tax assets.

Due to historical losses in the United States, the Company has a full valuation allowance on its United States federal and state deferred tax assets.

Management continues to evaluate the realizability of deferred tax assets and the related valuation allowance.

4 unchanged sentences

Fiscal years 2020, 2021 and 2022 are subject to audit by the Israeli tax authorities.

For the six months ended September 30, 2022 and September 30, 2021, the Company incurred income tax expense (benefit) of $ 97,000 and ($ 130,000 ) on net losses before income taxes of ($ 7.1 million) and ($ 8.9 million), respectively.

For the nine months ended December 31, 2022 and December 31, 2021, the Company incurred income tax expense (benefit) of $ 181,000 and ($ 66,000 ) on net losses before income taxes of ($ 11.8 million) and ($ 13.4 million), respectively.

The provision (benefit) was calculated using the annualized effective tax rate method.

The Company’s estimated annual effective income tax rate, including discrete items, was approximately ( 1.69 %) and 0.49 % as of September 30, 2022 and 2021, respectively.

The annual effective tax rates as of September 30, 2022 and 2021 vary from the United States statutory income tax rate primarily due to valuation allowances in the United States, whereby pre-tax losses do not result in the recognition of corresponding income tax benefits and expenses and the foreign tax differential.

The Company’s estimated annual effective income tax rate, including discrete items, was approximately ( 2.16 %) and 0.28 % as of December 31, 2022 and 2021, respectively.

The annual effective tax rates as of December 31, 2022 and 2021 vary from the United States statutory income tax rate primarily due to valuation allowances in the United States, whereby pre-tax losses do not result in the recognition of corresponding income tax benefits and expenses and the foreign tax differential.

NOTE 7—FINANCIAL INSTRUMENTS

5 unchanged sentences

The fair value of available-for-sale securities included in the Level 1 category is based on quoted prices that are readily and regularly available in an active market.

As of September 30, 2022, the Level 1 category included money market funds of $ 11.5 million, which were included in cash and cash equivalents on the Condensed Consolidated Balance Sheets.

As of December 31, 2022, the Level 1 category included money market funds of $ 12.3 million, which were included in cash and cash equivalents on the Condensed Consolidated Balance Sheets.

Valuations based on observable inputs (other than Level 1 prices), such as quoted prices for similar assets at the measurement date;

2 unchanged sentences

The fair value of available-for-sale securities included in the Level 2 category is based on the market values obtained from an independent pricing service that were evaluated using pricing models that vary by asset class and may incorporate available trade, bid and other market information and price quotes from well-established independent pricing vendors and broker-dealers.

As of September 30, 2022, the Level 2 category included short-term investments of $ 5.4 million and long-term investments of $ 628,000 , which were comprised of certificates of deposit, government and agency securities.

As of December 31, 2022, the Level 2 category included short-term investments of $ 3.3 million, which were comprised of certificates of deposit, government and agency securities.

Valuations based on inputs that are unobservable and involve management judgment and the reporting entity’s own assumptions about market participants and pricing.

As of September 30, 2022, the Company’s Level 3 financial instruments measured at fair value on the Condensed Consolidated Balance Sheets consisted of the contingent consideration liability related to the acquisition of MikaMonu.

As of December 31, 2022, the Company’s Level 3 financial instruments measured at fair value on the Condensed Consolidated Balance Sheets consisted of the contingent consideration liability related to the acquisition of MikaMonu.

The fair value of the contingent consideration liability was initially determined as of the acquisition date using unobservable inputs.

4 unchanged sentences

Conversely, changes in the risk-adjusted discount rate would be accompanied by a directionally opposite change in the related fair value measurement and expense.

Subsequent to the acquisition date,

at each reporting period, the contingent consideration liability is re-measured to fair value with changes recorded in selling, general and administrative expenses in the Condensed Consolidated Statements of Operations.

During the most recent re-measurement of the contingent consideration liability as of September 30, 2022, the Company used a risk-adjusted discount rate of approximately 16.3 % to adjust the probability-weighted cash flows to their present value using probabilities ranging from 0 % to 80 % for the remaining contingent events.

The contingent consideration liability is included in contingent consideration, non-current on the Consolidated Balance Sheet at September 30, 2022 and March 31, 2022 in the amount of $ 1.9 million and $ 2.7 million, respectively.

Subsequent to the acquisition date, at each reporting period, the contingent consideration liability is re-measured to fair value with changes recorded in selling, general and administrative expenses in the Condensed Consolidated Statements of Operations.

During the most recent re-measurement of the contingent consideration liability as of December 31, 2022, the Company used a risk-adjusted discount rate of approximately 15.5 % to adjust the probability-weighted cash flows to their present value using probabilities ranging from 20 % to 90 % for the remaining contingent events.

The contingent consideration liability is included in contingent consideration, non-current on the Consolidated Balance Sheets at December 31, 2022 and March 31, 2022 in the amount of $ 1.9 million and $ 2.7 million, respectively.

The fair value of financial assets measured on a recurring basis is as follows (in thousands):

3 unchanged sentences

and Liabilities

September 30, 2022

December 31, 2022

Money market funds

9 unchanged sentences

Contingent consideration

The following table sets forth the changes in fair value of contingent consideration for the six months ended September 30, 2022 and 2021, respectively:

Six Months Ended September 30,

The following table sets forth the changes in fair value of contingent consideration for the nine months ended December 31, 2022 and 2021, respectively:

Nine Months Ended December 31,

(In thousands)

6 unchanged sentences

Available-for-sale debt securities with maturities greater than twelve months are classified as long-term investments when they are not intended for use in current operations.

Investments in available-for-sale securities are reported at fair value

with unrecognized gains (losses), net of tax, as a component of accumulated other comprehensive loss in the Condensed Consolidated Balance Sheets.

The Company had money market funds of $ 11.5 million and $ 16.1 million at September 30, 2022 and March 31, 2022, respectively, included in cash and cash equivalents on the Condensed Consolidated Balance Sheets.

Investments in available-for-sale securities are reported at fair value with unrecognized gains (losses), net of tax, as a component of accumulated other comprehensive loss in the Condensed Consolidated Balance Sheets.

The Company had money market funds of $ 12.3 million and $ 16.1 million at December 31, 2022 and March 31, 2022, respectively, included in cash and cash equivalents on the Condensed Consolidated Balance Sheets.

The Company monitors its investments for impairment periodically and records appropriate reductions in carrying values when declines are determined to be other-than-temporary.

The following table summarizes the Company’s available-for-sale investments:

September 30, 2022

December 31, 2022

(In thousands)

1 unchanged sentence

Certificates of deposit

Total short-term investments

Long-term investments:

Supranational obligations

Total long-term investments

Total short-term investments

March 31, 2022

8 unchanged sentences

Total long-term investments

The following table shows the gross unrealized losses and fair value of the Company’s investments with unrealized losses aggregated by investment category and length of time that individual securities have been in a continuous loss position as of September 30, 2022 and March 31, 2022, respectively.

September 30, 2022

The following table shows the gross unrealized losses and fair value of the Company’s investments with unrealized losses aggregated by investment category and length of time that individual securities have been in a continuous loss position as of December 31, 2022 and March 31, 2022, respectively.

December 31, 2022

Less Than 12 Months

10 unchanged sentences

The Company’s investment portfolio consists of both corporate and governmental securities that have a maximum maturity of three years .

All unrealized gains and losses are due to changes in interest rates and bond yields.

All unrealized gains and losses are due to changes in interest rates and bond

Subject to normal credit risks, the Company has the ability to realize the full value of all these investments upon maturity.

The deferred tax asset related to unrecognized gains and losses on short-term and long-term investments was $ 29,000 and $ 22,000 at September 30, 2022 and March 31, 2022, respectively.

As of September 30, 2022, contractual maturities of the Company’s available-for-sale investments were as follows:

The deferred tax asset related to unrecognized gains and losses on short-term and long-term investments was $ 19,000 and $ 22,000 at December 31, 2022 and March 31, 2022, respectively.

As of December 31, 2022, contractual maturities of the Company’s available-for-sale investments were as follows:

(In thousands)

6 unchanged sentences

Supplemental balance sheet information related to leases was as follows:

September 30, 2022

December 31, 2022

March 31, 2022

6 unchanged sentences

The following table provides the details of lease costs:

Three Months Ended September 30,

Six Months Ended September 30,

Three Months Ended December 31,

Nine Months Ended December 31,

(In thousands)

3 unchanged sentences

The following table provides other information related to leases:

Six Months Ended September 30,

Nine Months Ended December 31,

(In thousands)

7 unchanged sentences

Operating leases

The following table provides the maturities of the Company’s operating lease liabilities as of September 30, 2022:

The following table provides the maturities of the Company’s operating lease liabilities as of December 31, 2022:

Operating Lease

(In thousands)

2023 (Remaining six months)

2023 (Remaining three months)

Total undiscounted future cash flows

12 unchanged sentences

NOTE 10—STOCK-BASED COMPENSATION

As of September 30, 2022, 4,064,310 shares of common stock were available for grant under the Company’s Amended and Restated 2016 Equity Incentive Plan.

The following table summarizes the Company’s stock option activities for the six months ended September 30, 2022:

As of December 31, 2022, 3,528,901 shares of common stock were available for grant under the Company’s Amended and Restated 2016 Equity Incentive Plan.

The following table summarizes the Company’s stock option activities for the nine months ended December 31, 2022:

Number of Shares

1 unchanged sentence

Balance at March 31, 2022

Balance at September 30, 2022

( 1,420,537 )

( 1,057,642 )

Balance at December 31, 2022

Options vested and exercisable

1 unchanged sentence

The following table summarizes stock-based compensation expense by line item in the Condensed Consolidated Statements of Operations, all relating to employee stock plans:

Three Months Ended September 30,

Six Months Ended September 30,

Three Months Ended December 31,

Nine Months Ended December 31,

(In Thousands)

4 unchanged sentences

NOTE 11—RELATED PARTY TRANSACTION

The Company incurred non-recurring engineering service expense and production charges of approximately $ 197,000 and $ 80,000 during the six months ended September 30, 2022 and 2021, respectively, from Wistron Neweb Corp (“WNC”) in connection with the manufacturing of single-APU PCIe boards, to be used in the Company’s in-place associative computing product.

The Company incurred non-recurring engineering service expense and production charges of approximately $ 201,000 and $ 349,000 during the nine months ended December 31, 2022 and 2021, respectively, from Wistron Neweb Corp (“WNC”) in connection with the manufacturing of single-APU PCIe boards, to be used in the Company’s in-place associative computing product.

Haydn Hsieh, a member of the Company’s board of directors, is the Chairman and Chief Strategy Officer of WNC.

The amount owed to WNC, of $ 83,000 and $ 32,000 at September 30, 2022 and March 31, 2022, respectively, is included in accounts payable in the Condensed Consolidated Balance Sheets.

The amount owed to WNC, of $ 4,000 and $ 32,000 at December 31, 2022 and March 31, 2022, respectively, is included in accounts payable in the Condensed Consolidated Balance Sheets.

NOTE 12—SEGMENT AND GEOGRAPHIC INFORMATION

2 unchanged sentences

The following is a summary of net revenues by geographic area based on the location to which product is shipped:

Three Months Ended September 30,

Six Months Ended September 30,

Three Months Ended December 31,

Nine Months Ended December 31,

(In thousands)

4 unchanged sentences

Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.

What changed 10-Q

Item 1. Financial Statements